1. Endocrine and paracrine characteristics of neuroendocrine prostate cancer
   Tarana Arman et al, 2022, Frontiers in Endocrinology CrossRef
2. Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production
   Vytautas Leoncikas et al, 2016, Scientific Reports CrossRef
3. 5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer
   Ferdinando Fiorino et al, 2014, Journal of Medicinal Chemistry CrossRef
4. Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model
   Sifeng Qu et al, 2014, Molecular Oncology CrossRef
5. Serotonin Pathway in Cancer
   Pragathi Balakrishna et al, 2021, International Journal of Molecular Sciences CrossRef
6. Serotonin acts through YAP to promote cell proliferation: mechanism and implication in colorectal cancer progression
   Huangfei Yu et al, 2023, Cell Communication and Signaling CrossRef
7. Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs
   Eva Slabáková et al, 2021, Non-Coding RNA CrossRef
8. Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands
   Zdzisław Chilmonczyk et al, 2015, International Journal of Molecular Sciences CrossRef
9. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer
   S Xu et al, 2015, British Journal of Cancer CrossRef
10. Cytotoxic Agents in the Minor Alkaloid Groups of the Amaryllidaceae
    Jerald J. Nair et al, 2021, Planta Medica CrossRef
11. Alkaloids isolated from Haemanthus humilis Jacq., an indigenous South African Amaryllidaceae: Anticancer activity of coccinine and montanine
    M. Masi et al, 2019, South African Journal of Botany CrossRef
12. Mechanisms underlying probiotic effects on neurotransmission and stress resilience in fish via transcriptomic profiling
    Yoonhang Lee et al, 2023, Fish & Shellfish Immunology CrossRef
13. Increased risk for urological cancer associated with anxiety disorder: a retrospective cohort study
    Yung-Chan Chen et al, 2016, BMC Urology CrossRef
14. Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey
    Lin Chen et al, 2024, Asian Journal of Andrology CrossRef
15. Effects and related mechanisms of serotonin on malignant biological behavior of hepatocellular carcinoma via regulation of Yap
    Sushun Liu et al, 2017, Oncotarget CrossRef
16. Structure–affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors
    Silvia Franchini et al, 2014, European Journal of Medicinal Chemistry CrossRef
17. Revisiting monoamine oxidase inhibitors: A potential dual-action therapy for patients with prostate cancer and comorbid depression?
    Premysl Vlcek et al, 2023, Journal of Psychopharmacology CrossRef
18. Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents
    Zdzislaw Chilmonczyk et al, 2017, Pharmacological Reports CrossRef
19. High‐throughput screen identifies 5‐HT receptor as a modulator of AR and a therapeutic target for prostate cancer
    Momoe Itsumi et al, 2020, The Prostate CrossRef